Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Teva Pharmaceutical Industries, a partner of Perrigo, a developer, manufacturer and distributor of OTC and generic prescription (Rx) pharmaceuticals, has started shipping Triamcinolone Acetonide Nasal Spray.
Subscribe to our email newsletter
Triamcinolone Acetonide Nasal Spray is generic equivalent to Nasacort AQ of Sanofi which is indicated as a treatment for nasal symptoms of seasonal and year round allergies in adults and children six years of age and older.
The product was developed and will be manufactured at Perrigo.
Under an agreement signed between the companies, the generic drug will be sold by Teva and Perrigo is eligible to share the costs and benefits.
Teva was the first applicant to file a complete abbreviated new drug application (ANDA) with a Paragraph IV certification for Nasacort AQ.
Teva is set to launch the product with 180 days of generic exclusivity.